October 2026: Titan>FDA MAUDE>Adverse Events Report

The final frontier. Deciding when, if and how.
lasthope2.0
Posts: 374
Joined: Sat Oct 11, 2025 1:23 pm

October 2026: Titan>FDA MAUDE>Adverse Events Report

Postby lasthope2.0 » Mon Nov 16, 2026 8:02 am

Coloplast Titan IPP — FDA MAUDE Reports Received in October 2026
Detailed analysis of all 146 Titan-family reports FDA received Oct 1–31, 2026. Every narrative was read, and each report was grouped by the main problem it describes. Tools used: Google and Claude.

The short version
  • 146 reports: 141 filed by Coloplast, plus 5 forwarded by another manufacturer about Titans it didn't make.
  • 127 (87%) are coded "Required Intervention"; all of those with a narrative describe a revision, replacement, repair or explant.
  • Mechanical malfunctions: 93 reports (64%) (fluid loss, pump and other device failures). Median time from implant: 5 years (85 reports with an implant year). Median patient age for malfunction: 68 (42 reports with an age), range 29–85.
  • Fluid loss / tubing failure was the #1 problem: 68 reports (47%). Where a break location was given, the most common one was at or near the pump (8 of the 35 breaks).
  • Infection: 16 (11%). Every one with a known implant year involved a device implanted in 2025–2026.
  • Sizing and placement problems: 19 (13%) — the group most tied to surgical technique. Another 6 were erosion/extrusion.
  • 19 reports came from South Korea, mostly near-identical one-line "tubing leak" reports for August events — a reporting batch, not necessarily a trend.
  • Only 20 of 146 reports list the device as returned to Coloplast, and no report includes an analysis result yet.

Before reading too much into the numbers
  • These are counts of reports, not failure rates. MAUDE has no denominator (how many Titans are in service), so raw counts can't rank brands or months.
  • This is one month of reports. Treat any pattern as provisional until it shows up across several months.
  • Reporting is uneven. One overseas distributor channel sent a batch this month, and plenty of failures are never reported at all.
  • One report isn't always one patient. A few reports here are the same patient or event filed more than once (see Data notes).
  • "Injury" here mostly means needed surgery: of the 126 reports typed Injury, 125 are coded "Required Intervention" and 97 list "No Clinical Signs, Symptoms or Conditions" as the health effect.
  • Causes are as reported — brief and second-hand, mostly relayed by Coloplast reps or distributors. No report this month contains a Coloplast evaluation finding.
  • The categories below were assigned by reading each narrative alongside FDA's problem codes. They are not an FDA grouping.


1) What went wrong
One primary category per report (percentages rounded). "Pump / inflate / deflate" means no leak was reported. The fluid-loss breakdown is in section 2.

Code: Select all

CATEGORY                   N    %
Fluid loss / tubing       68  47%
Pump / inflate / deflate  22  15%
Infection                 16  11%
Malposition / migration   11   8%
Sizing                     8   5%
Erosion / extrusion        6   4%
Other mechanical           3   2%
Unspecified / no detail   11   8%
Literature report          1   1%
TOTAL                    146

FDA's health-effect codes flag erosion in 9 reports overall: the 6 above, plus 2 sizing reports and 1 infection report.
FDA event types: Injury 126, Malfunction 15, Other 5 (the 5 forwarded reports).

2) Fluid loss and tubing failures (68)
This is the classic failure where the device loses its saline and won't inflate. 53 of the 68 involve the tubing specifically.
  • Tubing break, crack, cut or hole described: 35
  • "Tubing leak" with no break described: 18
  • Leak or fluid loss, site not stated: 10
  • Cylinder leak or needle perforation: 3
  • Reservoir leak or hole: 2
Where the 35 breaks were:

Code: Select all

WHERE THE TUBING BROKE      N
At or near the pump         8
Pump-to-cylinder tubing     4
Reservoir tubing            3
Cylinder-tubing junction    2
Strain relief               1
Connector failure           1
"Left"/"right" only         2
Site not stated            14
TOTAL                      35

  • Timing: for tubing breaks and leaks with a known implant year (51 reports), the median was about 5 years in service. 10 were 10+ years old (oldest implanted 2007); 6 were in their first year or two.
  • Early failures worth noting: three reports from Jordan, all implanted in 2026 and all failing with fluid loss by mid-September; two describe "a cut in the tube connecting the reservoir". They come from three different lots, so not one bad batch, and the reports don't say what caused the cuts. Also: a 29-year-old's 2026 implant with a break in the reservoir and cylinder tubing, and two cylinder leaks in US devices implanted in 2026.
  • South Korea: all 19 reports came in through a distributor. 14 are near-identical one-liners ("removed and replaced due to a tubing leak"), 4 are infections and 1 has no narrative. 17 of the 19 events happened in August, and they reached FDA in batches between Oct 1 and Oct 29. Three more reports with the same distributor wording have no country listed.
  • Country mix matters: fluid loss was 36% of US reports (32 of 89) but 73% of reports coded to other countries (30 of 41). Reporting patterns differ by country, which is another reason not to over-read raw counts.
  • Other leak causes: a needle perforation of the cylinders (2019 implant), and a reservoir leak where dense scar tissue meant the old reservoir was left in place and a non-Coloplast device was implanted.

3) Pump, inflation and deflation problems — no leak reported (22)
  • Pump sticky, stuck, frozen, stiff, stopped or hard to work: 7. One pump was "frozen" in a man who hadn't used his implant in 4 years (heavy scar tissue around the pump, fluid still in the system). Another sticky pump showed no defect after removal.
  • Won't inflate, or only partly: 7. Includes a Titan Touch that hissed when pumped (air mixed with the fluid), a pump bulb that collapses, and a patient whose left cylinder has never fully inflated and bends sharply since surgery (hidden at first by swelling).
  • Deflation problems: 5, including slow unintended deflation, failure to deflate in two devices implanted in 2026, and a 27-year-old device (implanted around 1999, a pre-Titan Mentor model) that had trouble deflating.
  • Auto-inflation: 3. A reservoir replaced 3 weeks after the original surgery because of auto-inflation; a forwarded report of a Titan auto-inflating and causing pain (explanted); and a physician who has seen more auto-inflation since adopting HESO ("Hamdan extrainguinal sub-oblique", submuscular) reservoir placement, especially in muscular patients. He said it may or may not be related.
  • All 6 patient-initiated reports fall in this group (each reached FDA through a manufacturer, not from the patient directly).

4) Infection (16)
  • Early-phase: 12 involved devices implanted in 2026, 2 in 2025, 2 unknown. None of the known implant years was earlier than 2025.
  • What happened next: 10 removed and replaced; 1 switched to a malleable; 1 got a temporary malleable spacer (Tactra), then a new inflatable several days later; 4 removed and not replaced — all 4 from South Korea.
  • One infected device came from a lot with a recorded manufacturing nonconformance ("missed end of batch seal"). Coloplast states it is not related to the infection and gives no further detail.

5) Sizing, placement and erosion (25)
  • Sizing (8): 3 too long/oversized — one led to extrusion, one had a "pending distal erosion", and one man found the cylinder uncomfortable and got a shorter device. 2 too short/undersized. 3 not specified.
  • Malposition / migration (11): reservoir 4 (one migrated into the scrotum, two others migrated, one moved to midline); cylinders 4 (migration, two crossovers, and an SST deformity from tips not seated far enough); component not stated 1; pump 2 (high-riding; placement causing pain).
  • Erosion / extrusion (6): all in devices 0–4 years old. One cylinder herniated through weakened tissue mid-shaft; one patient was switched to a Genesis malleable.
  • In 3 reports the narrative itself blames the original surgery: "not placed correctly", "surgeon's original placement" with "poor dilation", and "surgeon error and potential cross over" (described as a "tricky 4+ hour case"). For two of these, Coloplast points to the placement instructions in the IFU.
  • This month's literature report (UK; 473 first-time gender-affirming IPPs, 56% Coloplast) found the estimated 5-year chance of reoperation for any cause fell from about 66% for the first case to about 33% by case 473, with cumulative center experience the only independent predictor. Revision for dissatisfaction was 21.9% overall, higher with Boston Scientific than Coloplast devices. (J Sex Med 2026;23(10):qdag297)

6) How long the devices had been in
Years from implant to event, by category:

Code: Select all

CATEGORY       0-1 2-4 5-9 10+ n/a
Fluid / tubing   9  19  27  10   3
Pump/infl/defl   6   5   5   1   5
Infection       14   0   0   0   2
Malposition      4   3   3   1   0
Sizing           4   1   3   0   0
Erosion          4   2   0   0   0
Other mech.      1   0   2   0   0
Unspecified      2   0   2   2   5
Literature       0   0   0   0   1
ALL             44  30  42  14  16

Event year minus implant year. Only the year is reported, so each figure is ±1. n/a = implant year not reported.
  • Infections show up in the first year or so; sizing, placement and erosion problems mostly within 4 years (18 of 25); tubing failures are spread out, mostly at 2–9 years.
  • 32 reports (22%) involved devices implanted in 2026; 12 of those were infections.
  • Long-lived devices in this batch: a pre-Titan Mentor device implanted around 1999 (27 years, trouble deflating), two from 2007 (about 19 years: one tubing break, one "not working"), and a 2009 Titan (about 17 years, tubing fracture near the pump).

7) Where the reports came from
  • United States 89 — FL 21, NY 14, TX 9, PA 6, IL 6, OH 4, GA 4, NJ 3, CO/ID/VA 2 each, 8 other states 1 each, state missing 8. State counts aren't rates; they track where reporting surgeons practice and how many implants they do.
  • South Korea 19, Australia 6, Jordan 3, Spain 2, Vietnam 2, and 1 each from Canada, Colombia, Egypt, France, Italy, Netherlands, Portugal, UK and "CI" (see Data notes). Country missing: 16.
  • Who reported: health professional via a Coloplast rep 84; foreign health professional via a distributor 31; other foreign health professional 13; patients 6; health professional direct 5; literature 1; not stated 6.
  • Patient age (given in 63 of 146): median 68, range 29–85. 60s: 26, 70s: 21, 50s: 11, 80s: 3, 40s: 1, 20s: 1.

8) Which Titan versions
Decoded from catalog numbers using Coloplast's Titan ordering list (for cylinder sets, the last two digits are the length in cm):

Code: Select all

TITAN SET (catalog)          N
Touch pump (ES28/ES29)      52
Titan pump (ES88/ES89)      31
Touch pump, NB (EN28/EN29)  19
Titan pump, NB (EN88/EN89)   2
XL cylinders (E179..)        3
Reservoir (ER8075/ER8125)    7
Older codes (Q.., 90-9x..)   9
Other (517750/517770)        6
Not reported                17

Touch pump / Titan pump = the pump supplied with the cylinder set. NB = Narrow Base cylinders.
  • Cylinder lengths (ES/EN sets): 20 cm 32, 22 cm 31, 18 cm 20, 16 cm 14, 14 cm 4, 24 cm 2, 11 cm 1. This mostly mirrors what gets implanted; it doesn't show any size failing more.
  • 12 of the 19 Korean reports were Narrow Base (EN) sets.
  • The older-generation codes belonged to devices implanted between 1999 and 2018 (where the year is given). The 1999 device predates the Titan name (see Data notes).

9) What Coloplast's investigations said
  • 112 reports say the lot was reviewed and its devices met specification at release; nearly all add that no complaint trends, nonconformances or CAPAs were found.
  • 103 say the device was not returned or received, so Coloplast says it can't comment on the device's condition.
  • 20 devices are listed as returned (Sept 24–Oct 28) and 2 reports are flagged "evaluated", but no report contains an evaluation finding; results, if any, would come later as follow-up reports (10 reports already include a follow-up).
  • 14 reports say no lot or history review was possible because no lot number was provided. Overall, 20 reports have no lot number on file and 17 have no catalog number.
  • Exceptions: 2 lots had "several complaints" but with different failure modes, so Coloplast didn't treat them as a trend; 1 lot had the nonconformance mentioned under Infection; 2 reports where Coloplast points to the original surgical placement; and a phalloplasty patient's tubing failure that Coloplast classes as off-label use, because the labeled indication is men with ED.
  • 19 reports (including the 5 forwarded ones) have no manufacturer narrative at all.

10) The 5 forwarded reports
These are voluntary reports carrying FDA's note that they arrived under 21 CFR 803.22(b)(2), the rule for a manufacturer passing along a complaint about a device it didn't make. Two refer to "non-BSC" devices, and one of those also mentions a Tactra (Boston Scientific's malleable), so the sender appears to be Boston Scientific.
  • A Titan auto-inflating and causing pain; explanted.
  • An infected Titan; explanted, Tactra as a temporary spacer, new inflatable several days later.
  • Three near-identical reports of a patient whose "three previous" devices "did not work properly" — very likely one patient, three devices.
  • All 5 show a report date of 04/30/2026 but FDA-received dates of Oct 15 and Oct 21, 2026.

11) Notable individual reports
  • A 29-year-old, implanted 2026: break in the reservoir and cylinder tubing.
  • Reservoir replaced for auto-inflation 3 weeks after the original surgery.
  • A 125 cc reservoir would only hold 60 cc.
  • Reservoir leak; dense scar tissue, so the old reservoir was left in place and a non-Coloplast implant was used.
  • Small hole spotted in a reservoir while prepping it in the OR; swapped before implanting (no patient harm reported).
  • Needle perforation of the cylinders (2019 implant).
  • Pump "frozen" after 4 years of no use, heavy scar tissue around it.
  • Physician trend report on auto-inflation with HESO placement in muscular patients.
  • Titan Touch that wouldn't inflate; hissing when pumped (air mixed with the fluid).
  • From a patient: left side never fully inflated and bends sharply since surgery; hasn't seen his urologist yet.
  • A 27-year-old pre-Titan Mentor device (implanted around 1999) with trouble deflating.

12) Data notes (for the data-minded)
  • Same event or patient filed more than once: One event was split into two reports (broken tubing in one, undersizing in the other). Two other reports look like one patient (same event date, state, age, implant year and return date; one covers the cylinders, the other the reservoir). The three "three previous devices" forwarded reports are likely one patient. The two Vietnam reports share a lot number and implant year.
  • Impossible or conflicting dates: One report lists a 2020 implant for a device made in March 2021 (another report from the same lot says 2022). Another device's expiration date (Nov 2023) is before its listed 2024 implant year, so either an expired device was implanted or a date is wrong. A third says the leak came "after 10 years" but lists a 2022 implant.
  • Contradictions: One report is flagged "evaluated by manufacturer" while its narrative says the device was not received. In another, the event text (from a follow-up) says explanted and replaced, but the manufacturer narrative still says "remains implanted". A third has a lot number on file, but its narrative says no lot was provided (it also had a follow-up, so the narrative may predate the lot).
  • "Titan" is a family label: Coloplast names the device in these reports as the "Titan inflatable penile prosthesis family" and files them under one FDA approval (PMA P000006). That approval was first granted in July 2000 for the Mentor Alpha I; the Titan name came later. The device reported as 27 years old (implanted around 1999, with an older Mentor catalog code) is therefore a pre-Titan Mentor model, not a Titan.
  • FDA's own problem codes (a report can carry several): Fluid/Blood Leak 40, Fracture 34, Adverse Event Without Identified Device or Use Problem 17, Inflation Problem 14, Insufficient Device Problem Information 9, Inadequacy of Device Shape and/or Size 8, Malposition of Device 8, Migration 6.
  • Completeness: patient sex "Unknown" on 124 of 146; age missing on 83; weight, race, ethnicity and UDI blank on all 146; 13 reports have no event description at all.
  • Country codes are mixed: Denmark appears as DA, Spain SP, Vietnam VM and Portugal PO (older FIPS-style codes), but South Korea is KR and the UK is GB (ISO codes). That leaves AU (Australia or Austria) and CI (Chile or Côte d'Ivoire) ambiguous; AU is most likely Australia.
  • Numbering gaps: 13 numbers in Coloplast's report sequence for this month are missing from this set. They may be other products or reports not yet released; this data can't say.
  • Timeliness: median 17 days from event to FDA receipt; 98 of 138 dated reports arrived within 30 days. The big outliers are a December 2022 event and a 2021 literature case. (The 30-day MDR clock starts when the manufacturer learns of an event, not on the event date.)

13) Practical takeaways
Informational only, not medical advice. Talk to your surgeon about your own situation.
  • Keep your implant card (catalog and lot numbers). 20 reports had no lot number on file, and 14 manufacturer narratives say the lot review couldn't be done because no lot was provided.
  • Facing a revision? Ask whether the explanted device will go back to Coloplast for analysis. Only 20 of 146 reports list the device as returned this month, and without the device Coloplast says it can't comment on its condition.
  • Infections cluster early: every infection report with a known implant year involved a device implanted in 2025–2026.
  • Sizing and placement problems (19 reports) are the ones most tied to surgical technique. Three narratives blame the original surgery outright, and this month's literature report (gender-affirming IPPs) found cumulative center experience to be the only independent predictor in its analysis.
  • Patients can report directly to FDA through MedWatch (online, or by phone at 1-800-FDA-1088). This month only 6 of 146 reports started with a patient, and none was filed by a patient directly.

Source: FDA MAUDE, Coloplast Titan inflatable penile prosthesis family, reports received by FDA Oct 1–31, 2026. Catalog decoding per Coloplast's Titan ordering information. Counts are reports, not rates. Anyone can search MAUDE on FDA's website, and FDA's MAUDE page explains the database's limitations.
24 Genesis SC 22-13, 5.5-4.5 ; 26 Titan Classic PS 22, 6-5

User avatar
Bearskin777
Posts: 107
Joined: Tue Jul 21, 2026 6:26 am
Location: Atlanta

Re: October 2026: Titan>FDA MAUDE>Adverse Events Report

Postby Bearskin777 » Mon Nov 16, 2026 8:27 am

Can you offer some context for this? Just FYI? Specific complaints with your own Titan?
61 yrs old, gay, married. Atlanta.
ED for 10 yrs, Peyronies 2 yrs.
Titan, by Dr. Hakky October 20, 2026. 25.5cm (24 cm with 1.5 RTE)
7"x6" pre-Peyronies, 6.25 x 6.25" post-Peyronies. Post-op size TBD. Will do Show-n-Tell

cbinspok
Posts: 1189
Joined: Wed Feb 03, 2021 7:45 pm

Re: October 2026: Titan>FDA MAUDE>Adverse Events Report

Postby cbinspok » Mon Nov 16, 2026 8:41 am

Damn! some awful numbers from Titan
71 years now,Ed twenty years. A sever break to penis, vit E, pataba, Viagra, massage Ved cilas, exhausted, I tossed in my towel, Op for implant Mar 18, 2021 AMS LGX 18 x12 + 1 3cm RTE,yep standard size, happily gained girth and length,.. stay hwp!

lasthope2.0
Posts: 374
Joined: Sat Oct 11, 2025 1:23 pm

Re: October 2026: Titan>FDA MAUDE>Adverse Events Report

Postby lasthope2.0 » Tue Nov 17, 2026 11:55 pm

Hey Bionic Bros,
Apologies for the late follow-up. Here's a less tedious version without all the boring numbers, counts and percentages! I found this to be more educational.

A summary without the numbers

Overview
Most of October's Titan reports describe revision surgery, where the device was removed and usually replaced. The main pattern is fluid loss, mostly from tubing that leaks, cracks or breaks. When a report gives a location, it is most often at or near the pump. Infection is the other major driver, and it is the cause in every report that says the device was removed and not replaced. Smaller themes are pump problems, auto-inflation, erosion, sizing and surgical technique, parts moving out of place, and old devices wearing out. No report mentions a death.

Tubing failure types and locations
Tubing failures are by far the most common theme. Reports describe leaks, breaks, cracks, cuts, holes, ruptures, a failed tubing connection, and "tubing erosion" (labeled as fracture). When a location is given, it is most often at or near the pump, including where the tubing leaves it. Others were where the tubing meets a cylinder, at the strain relief, or along the lines to the cylinders and reservoir. In one revision, the tubes between the pump and cylinders had been pierced in several places, and the report doesn't say how.

Tubing failure symptoms and repairs
Patients usually lost fluid and couldn't inflate the device. In one case, an ultrasound showed an empty reservoir, and surgery then found a rupture at the strain relief. Most devices were fully replaced. Smaller fixes included replacing just the pump and repairing the tubing while keeping the original device. In one pump-only replacement, the broken section was cut off and the other parts were tested first.

Other leaks and inflation failures
Reports describe leaking cylinders, leaks with no source given, a device that wouldn't fill when pumped, and slow deflation on its own. One device was found empty with no hole, and another had little fluid left, with cylinders that slowly drained. One pump had air in it, and a Titan Touch hissed when pumped, suggesting air mixed with fluid.

Reservoir leaks and defects
One reservoir would no longer hold its full rated volume. In another case, a device worked well for years, then suddenly wouldn't inflate. Its leaking reservoir was surrounded by dense scar tissue, so the reservoir was left in and the Titan was replaced with another company's implant. Separately, a small hole was found in a reservoir while it was being prepared, before implant, and a new reservoir was used.

Problems with no revision reported
Some patients haven't had revision surgery yet. One says his device no longer fully inflates and the pump bulb collapses, and his clinic told him he will likely need a replacement. Another says his left side has never fully inflated and bends sharply, while the right side works. It only became noticeable once swelling after surgery went down, and he hasn't seen his urologist yet. A separate report describes a pump that gets stuck and won't inflate, with no surgery mentioned.

Pump problems
Some pumps were sticky or frozen. One had no defect when removed. Another belonged to a patient who hadn't used the device in four years and had heavy scar tissue around the pump, with fluid still in the system. A revision for a suspected sticky pump found broken tubing instead. Other reports describe a hard pump, a pump that was difficult to activate, trouble pumping, and a pump that stopped working. Position problems include a pump sitting too high and a pump whose position caused pain.

Auto-inflation
This is a small theme but worth watching. A physician says he is seeing more auto-inflation. He isn't sure whether it is linked to the HESO (Hamdan extra-inguinal sub-oblique) submuscular placement he started using, but his muscular patients seem affected more often. In another case, a reservoir was replaced for auto-inflation within weeks of the original surgery. A MedWatch report also describes a Titan the patient had stopped using that was auto-inflating and causing pain. The physician confirmed problems during revision, and the device was removed.

Infection
Most infected devices were removed and replaced, including one switched to a malleable implant. The rest were removed with nothing put back. Some reports add detail: infection from the earlier surgery, pain with possible infection, and infection with erosion. A MedWatch report describes a two-step approach for an infected device it doesn't name. A temporary malleable spacer (Tactra) went in first, then a new inflatable several days later, with no further problems.

Erosion and extrusion
Reports include cylinders that had pushed out through tissue (extrusion), cases where this was about to happen, and erosion on its own. One extruded device was replaced with a Genesis malleable. Oversizing was blamed for one extrusion, and for a too-long device with erosion starting at the tip.

Sizing and placement problems
Some cylinders were too short, undersized or "incorrectly sized." In one of these, the left tubing was also broken when removed. Another patient found his cylinders uncomfortable and was given a shorter device. An SST deformity (drooping glans) was blamed on the original placement and poor dilation, which left the cylinder tips short of where they should sit.

Cylinder crossover and needle puncture
Some reports describe cylinder crossover, where a cylinder ends up in the opposite erectile chamber. One long, difficult case was put down to surgeon error and possible crossover, though the physician leaned toward unusual anatomy. The device was removed and a malleable put in so the patient could heal before new scans and another inflatable. Another revision found a needle puncture in the cylinders.

Component migration and cylinder aneurysm
Several reservoirs moved, including one that slipped into the scrotum because it wasn't placed correctly. In another revision, a reservoir was moved to the midline. Cylinders also moved, including one bulging through weakened tissue in the middle of the shaft. One report describes a migration without saying which part moved, and another describes a cylinder aneurysm.

Long-implanted devices
Several devices failed after many years in place. At 20 years, one stopped working. One over 15 years old stopped working for an unknown reason. One over 10 years old was "not as efficient," though no tubing fracture was found, the pump still had fluid and the cylinders looked fine. At 10 years, one developed a leak, and at 9 years, one had its tubing break at the pump.

Phalloplasty case
A patient who had a third-stage phalloplasty in 2024 had a fluid leak from broken tubing, and the device was replaced. The report doesn't say why he had the phalloplasty.

Published study
A literature report covers a study from a single institution's database of first-time inflatable implants in gender-affirming surgery, using Boston Scientific and Coloplast devices. It looked back at five-year reoperation for any reason and five-year revision for dissatisfaction, and found both improved as the institution gained experience. Revision for dissatisfaction was more common with Boston Scientific than Coloplast devices. The only independent predictor was the institution's experience, and flap type and number of cylinders weren't significant. Problems cited include reoperation for dissatisfaction (including poor positioning) and reoperation for any reason, such as infection or malfunction.

Reports with little or no cause
Some replacements give "unknown," "unspecified" or plain "malfunction" as the reason. In one revision, the surgeon couldn't find the cause or location of the failure, so the whole set was replaced. One explanted device was returned for analysis with no other details. MedWatch notices describe a patient whose earlier devices "did not work properly" and were replaced. They seem to come from Boston Scientific, since they mention "non-BSC" devices, and the device names are blacked out.
24 Genesis SC 22-13, 5.5-4.5 ; 26 Titan Classic PS 22, 6-5

User avatar
Bearskin777
Posts: 107
Joined: Tue Jul 21, 2026 6:26 am
Location: Atlanta

Re: October 2026: Titan>FDA MAUDE>Adverse Events Report

Postby Bearskin777 » Wed Nov 18, 2026 6:08 am

This does look easier to digest, but I repeat my question: what's the context? Since you recently got one, is there a beef with Titans vs something else?

I'm really curious because lately I've been seeing more of these long, cranky AI-derived screeds without any indication of why they're being posted. One guy sounded like he was condemning ALL reports and studies about devices, simply because the numbers came from the manufacturers which he feels aren't trustworthy or authoritative and AI gives better data. [My bias: I've worked with science and public health researchers for 30 years and we're seeing that AI is incredible at pulling anecdotal stuff (from FT and Reddit for example), but for actual research -- not so reliable because it suffers from data hallucinations and fills in artificial citations and literature reviews with what it assumes the user is looking for.] I'm not opposed to the info, but it helps to know the background story and why I should want to read them. It's also a little daunting without that: I hit my one-month mark yesterday and don't really want to know all the potential fuckery behind my shiny new Titan quite this early. I haven't even taken it for a test drive yet!!!
Last edited by Bearskin777 on Wed Nov 18, 2026 9:14 am, edited 2 times in total.
61 yrs old, gay, married. Atlanta.
ED for 10 yrs, Peyronies 2 yrs.
Titan, by Dr. Hakky October 20, 2026. 25.5cm (24 cm with 1.5 RTE)
7"x6" pre-Peyronies, 6.25 x 6.25" post-Peyronies. Post-op size TBD. Will do Show-n-Tell

User avatar
ElbowRoom
Posts: 1384
Joined: Mon Mar 17, 2025 1:58 pm

Re: October 2026: Titan>FDA MAUDE>Adverse Events Report

Postby ElbowRoom » Wed Nov 18, 2026 8:39 am

cbinspok wrote:Damn! some awful numbers from Titan


Are they? This seems mostly in line with monthly failure reports from both Coloplast and BS. The trend is typical...a lot of tubing failures, and few other faulure types. Usually BS has similar failure numbers, but more evenly distributed among components.

This is the reason many of us hope the Titan Prime will be a game changer...the reinforced tubing in that model might significantly reduce overall Titan failures.
59yo Coloplast Titan 28cm Penoscrotal with Dr. Hakky 10/21/2025.
Pre-op erect measurements:
8.5"L and 6.4”C

Post-op: 8.9” L and 6.2” C at 10 months

cbinspok
Posts: 1189
Joined: Wed Feb 03, 2021 7:45 pm

Re: October 2026: Titan>FDA MAUDE>Adverse Events Report

Postby cbinspok » Wed Nov 18, 2026 9:15 am

hey , In my thoughts, any failure regardless of this or that , any failure that puts you back on the table for a revision is not ok.
It seems to me these numbers across all brands are too high.
we have brothers on this page who have endured multiple surgeries and mental setbacks/ stress because the equipment or the implanter has done something incorrect.
It definitely gives one pause when it shouldn't feel like gambling.
71 years now,Ed twenty years. A sever break to penis, vit E, pataba, Viagra, massage Ved cilas, exhausted, I tossed in my towel, Op for implant Mar 18, 2021 AMS LGX 18 x12 + 1 3cm RTE,yep standard size, happily gained girth and length,.. stay hwp!

whatevery
Posts: 240
Joined: Fri Oct 31, 2025 3:10 pm

Re: October 2026: Titan>FDA MAUDE>Adverse Events Report

Postby whatevery » Wed Nov 18, 2026 10:54 am

ElbowRoom wrote:
cbinspok wrote:Damn! some awful numbers from Titan


Are they? This seems mostly in line with monthly failure reports from both Coloplast and BS. The trend is typical...a lot of tubing failures, and few other faulure types. Usually BS has similar failure numbers, but more evenly distributed among components.

This is the reason many of us hope the Titan Prime will be a game changer...the reinforced tubing in that model might significantly reduce overall Titan failures.


The way I see it is since soon after being introduced both One Touch and Tenatio pumps went through their respective recalls, and that apparently Coloplast redesigned pump, cylinders and tubes for its Prime device, I'm willing to follow Mitt Romney and offer a $10,000 bet that Prime would undergo some sort of recall, whether mandatory or voluntary, within first 2 years of it hitting the market. :P
65 yrs old.
ED since about 2000.
Just moved to Trimix from Edex few months ago.
Implant doctor shopping now but doing BPH first.


Return to “Implants”

Who is online

Users browsing this forum: biobob, ClaudeBot, Facebook, treetop and 45 guests